Search

Nanotechnologies : a preliminary risk analysis on the basis of a workshop organized in Brussels on 1-2 march 2004 by the health and consumer protection directorate general of the European Commission

<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<rdf:Description>
<dc:creator>Comisión Europea</dc:creator>
<dc:date>2004</dc:date>
<dc:description xml:lang="es">Sumario: Nanotechnologies refer to "technologies of the tiny". They span domains as diverse as computing, material science, medicine, energy production and storage, etc., bring together fields as varied as physics, chemistry, genetics, information and communication technologies, and cognitive sciences, and should become virtually ubiquitous before long.Nanotechnologies are with us already. Indeed, consumers are already being offered products manufactured with nanotechnologies including cosmetics, clothing, and sporting goods. But, while technology and market analysts alike expect the very small to become very big, nanotechnologies are still emerging.The "Mapping out Nano Risks" workshop represents a modest first step, albeit an important one, towards analyzing the potential risks of nanotechnologies and what they may imply</dc:description>
<dc:identifier>https://documentacion.fundacionmapfre.org/documentacion/publico/es/bib/117560.do</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>European Commission, Community Health and Consumer Protection</dc:publisher>
<dc:rights xml:lang="es">InC - http://rightsstatements.org/vocab/InC/1.0/</dc:rights>
<dc:subject xml:lang="es">Nanotecnología</dc:subject>
<dc:subject xml:lang="es">Análisis de riesgos</dc:subject>
<dc:subject xml:lang="es">Etica social</dc:subject>
<dc:subject xml:lang="es">Riesgo tecnológico</dc:subject>
<dc:type xml:lang="es">Books</dc:type>
<dc:title xml:lang="es">Nanotechnologies : a preliminary risk analysis on the basis of a workshop organized in Brussels on 1-2 march 2004 by the health and consumer protection directorate general of the European Commission</dc:title>
</rdf:Description>
</rdf:RDF>